Search Results for "Asahi Kasei A Bpep"

06:21 EDT 29th September 2016 | BioPortfolio

Matching Channels


Matching News

Asahi Kasei licenses Asian rights to Array's ARRY954 in pain, inflammation

Asahi Kasei Corp.'s Asahi Kasei Pharma Corp. division will develop and commercialize Array BioPharma Inc.'s tropomyosin receptor kinase A (TrkA) inhibitors for pain, inflammation, and other indication...

Basilea licenses isavuconazole to Asahi Kasei in Japan

Swiss drugmaker Basilea Pharmaceutica has entered into a partnering agreement with Asahi Kasei Pharma…

Array BioPharma links with Asahi Kasei on TrkA inhibitors

Array BioPharm and Japan’s Asahi Kasei Pharma Corp have entered a strategic collaboration to develop…

Array BioPharma to collaborate with Asahi Kasei on pain treatments

Array BioPharma will partner with Asahi Kasei Pharma on the development and marketing of its tropomyosin receptor kinase A in -More- 

BRIEF-Orion Corporation and Asahi Kasei enters into global strategic collaboration

* Says that it has entered into a global strategi collaboration agreement with Japanese Asahi Kasei Pharma for the discovery, development and commercialisation of assets in pain management

PeptiDream in research collaboration with Asahi Kasei Pharma

Asahi Kasei Pharma has become the latest company to join forces with PeptiDream in a research deal.

Orion and Asahi Kasei reach agreement for pain management assets

Finnish pharmaceutical and diagnostics company Orion has entered a global strategic collaboration agreement with Japan-based Asahi Kasei Pharma to discover, develop and commercialise assets in pain ma...

Array BioPharma, Asahi Kasei Pharma collaborate for novel pain and inflammation program

Array BioPharma and Asahi Kasei Pharma announced a strategic collaboration to develop and commercialize select Tropomyosin receptor kinase A (TrkA) inhibitors, including Array-invented ARRY-954, for p...

Matching PubMed Articles

Blood Pressure Effects of Yoga, Alone or in Combination With Lifestyle Measures: Results of the Lifestyle Modification and Blood Pressure Study (LIMBS).

The authors conducted a study to assess the effects of yoga on blood pressure (BP). Patients were randomized to yoga (Blood Pressure Education Program [BPEP]), or a combined program (COMBO). Ambulator...

Initial Experience With the Gaia Composite Core Guidewires in Coronary Chronic Total Occlusion Crossing.

Inability to cross the occlusion with a guidewire is the most common cause of failure of coronary chronic total occlusion (CTO) interventions. We describe two cases of successful application of the no...

C-Peptide Level in Fasting Plasma and Pooled Urine Predicts HbA1c after Hospitalization in Patients with Type 2 Diabetes Mellitus.

In this study, we investigate how measures of insulin secretion and other clinical information affect long-term glycemic control in patients with type 2 diabetes mellitus. Between October 2012 and Jun...

Search Whole site using Google

Quick Search
Advertisement Advertisement